Comparison of Prognostic Risk Models (IMDC, MSKCC, CFF) in Patients Diagnosed with Metastatic Renal Cell Cancer
Objective: The aim of this study is to reveal the relationship and correlation between the International metastatic renal cell carcinoma (mRCC) Database Consortium (IMDC) and Memorial Sloan Kettering Cancer Center (MSKCC) risk models used to determine first-line treatment in metastatic mRCC and, les...
Saved in:
| Main Authors: | Merve KESKİNKILIÇ, Kübra CANASLAN, Hüseyin Salih SEMİZ, Tuğba YAVUZŞEN |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2025-08-01
|
| Series: | Forbes Tıp Dergisi |
| Subjects: | |
| Online Access: | https://forbestip.org/articles/comparison-of-prognostic-risk-models-imdc-mskcc-cff-in-patients-diagnosed-with-metastatic-renal-cell-cancer/doi/forbes.galenos.2025.78309 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rare Metastatic Pathways of Renal Cell Carcinoma: Duodenal Involvement and Therapeutic Challenges
by: Supriya Peshin, et al.
Published: (2025-07-01) -
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)
by: Salma Binzaqr, et al.
Published: (2025-04-01) -
A Cleveland model?
by: Alessandro Coppola
Published: (2014-12-01) -
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma
by: Ilya Tsimafeyeu, et al.
Published: (2025-04-01) -
Exceptional Response in a Patient with mRCC Through Precision-Guided Treatment Involving Immunotherapy Rechallenge with Temsirolimus and Bevacizumab
by: Ashkan Adibi, et al.
Published: (2025-05-01)